ReviewJournal of hematology & oncology2024

Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives.

Yuhang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.